282 related articles for article (PubMed ID: 15964637)
21. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
[TBL] [Abstract][Full Text] [Related]
22. Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.
Rojas-Marcos I; Picard G; Chinchón D; Gelpi E; Psimaras D; Giometto B; Delattre JY; Honnorat J; Graus F
Neuro Oncol; 2012 Apr; 14(4):506-10. PubMed ID: 22351748
[TBL] [Abstract][Full Text] [Related]
23. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction.
Debes JD; Lagarde SM; Hulsenboom E; Sillevis Smitt PA; ten Kate FJ; Sulter GA; van Lanschot JJ
Dig Surg; 2007; 24(5):395-7. PubMed ID: 17785986
[TBL] [Abstract][Full Text] [Related]
24. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.
Luque FA; Furneaux HM; Ferziger R; Rosenblum MK; Wray SH; Schold SC; Glantz MJ; Jaeckle KA; Biran H; Lesser M
Ann Neurol; 1991 Mar; 29(3):241-51. PubMed ID: 2042940
[TBL] [Abstract][Full Text] [Related]
25. Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay.
Storstein A; Monstad SE; Nakkestad HL; Husebye ES; Vedeler CA
J Neurol; 2004 Feb; 251(2):197-203. PubMed ID: 14991355
[TBL] [Abstract][Full Text] [Related]
26. [Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy].
Qian W; Lu Y; Chen Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):196-8. PubMed ID: 12903528
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to cerebellar nerve fibres in two patients with paraneoplastic cerebellar ataxia.
Balegno S; Ceroni M; Corato M; Franciotta D; Giometto B; Marinu-Aktipu K; Nano R
Anticancer Res; 2005; 25(5):3211-4. PubMed ID: 16101129
[TBL] [Abstract][Full Text] [Related]
28. CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration.
Eichler TW; Totland C; Haugen M; Qvale TH; Mazengia K; Storstein A; Haukanes BI; Vedeler CA
PLoS One; 2013; 8(6):e66002. PubMed ID: 23823982
[TBL] [Abstract][Full Text] [Related]
29. Paraneoplastic cerebellar degeneration mimicking development of secondary progressive multiple sclerosis in a patient with relapsing-remitting multiple sclerosis.
Gracien R; Kordulla M; Ziemann U
Mult Scler; 2011 Apr; 17(4):498-500. PubMed ID: 21148018
[TBL] [Abstract][Full Text] [Related]
30. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration.
Albert ML; Austin LM; Darnell RB
Ann Neurol; 2000 Jan; 47(1):9-17. PubMed ID: 10632096
[TBL] [Abstract][Full Text] [Related]
31. Ovarian cancer: PCD and brain metastases.
Stepanić V; Matković V; Corusić A; Barisić D; Buković D; Ilić-Forko J
Coll Antropol; 2007 Jun; 31(2):633-6. PubMed ID: 17847951
[TBL] [Abstract][Full Text] [Related]
32. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
[TBL] [Abstract][Full Text] [Related]
33. The immunopathogenesis of paraneoplastic neurological syndromes.
Sutton I; Winer JB
Clin Sci (Lond); 2002 May; 102(5):475-86. PubMed ID: 11980564
[TBL] [Abstract][Full Text] [Related]
34. Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate.
Greenlee JE; Clawson SA; Hill KE; Dechet CB; Carlson NG
J Neurol Sci; 2010 Apr; 291(1-2):74-8. PubMed ID: 20089262
[TBL] [Abstract][Full Text] [Related]
35. Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degeneration.
Sindic CJ; Andersson M; Boucquey D; Chalon MP; Bisteau M; Brucher JM; Laterre EC
Acta Neurol Belg; 1993; 93(2):65-77. PubMed ID: 8506746
[TBL] [Abstract][Full Text] [Related]
36. Proteasome antibodies in patients with cancer or multiple sclerosis.
Thuy-Tien H; Haugen M; Aarseth J; Storstein A; Vedeler CA
Scand J Immunol; 2008 Apr; 67(4):400-3. PubMed ID: 18266796
[TBL] [Abstract][Full Text] [Related]
37. Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.
Bradwell AR
Clin Rev Allergy Immunol; 2000 Aug; 19(1):19-29. PubMed ID: 11064823
[No Abstract] [Full Text] [Related]
38. Isolated ZIC4 antibodies in paraneoplastic cerebellar syndrome with an underlying ovarian tumor.
Kerasnoudis A; Rockhoff M; Federlein J; Gold R; Krogias C
Arch Neurol; 2011 Aug; 68(8):1073. PubMed ID: 21825246
[TBL] [Abstract][Full Text] [Related]
39. Paraneoplastic syndromes associated with anti-Hu antibodies.
Senties-Madrid H; Vega-Boada F
Isr Med Assoc J; 2001 Feb; 3(2):94-103. PubMed ID: 11344832
[TBL] [Abstract][Full Text] [Related]
40. Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.
Raspotnig M; Haugen M; Thorsteinsdottir M; Stefansson I; Salvesen HB; Storstein A; Vedeler CA
Cancer Immunol Immunother; 2017 Nov; 66(11):1463-1471. PubMed ID: 28710511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
